Molecular Technologist II (High Complexity) at Tempus

Chicago, Illinois, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Genomics, BiotechnologyIndustries

Requirements

MS in medical technology, clinical laboratory science, chemical, physical or biological science OR BS in medical technology, clinical laboratory science, chemical, physical or biological science
Curriculum: At least 60 semester hours, or equivalent, from an accredited institution that, at a minimum, includes either: 24 semester hours of medical laboratory technology courses; or 24 semester hours of science courses that include: 6 semester hours of chemistry; 6 semester hours of biology; and 12 semester hours of chemistry, biology, or medical laboratory technology in any combination
2+ years of post-baccalaureate (post-BS degree) clinical experience in a CAP/CLIA high-complexity laboratory (such as molecular pathology, molecular diagnostics, microbiology lab, forensics/drug testing lab, etc)
At least 1 year experience executing NGS workflows and molecular biology techniques, such as nucleic acid extraction, library preparation, hybridization/capture and sequencing
Experience in a CAP/CLIA high complexity clinical laboratory setting
Excellent communication skills
Thrives in a fast-paced environment
Ability to work with others to plan and carry out scientific programs
Self-driven and works well in an interdisciplinary team with minimal direction
Strong desire to build products that will save lives and change the course of cancer
Impeccable attention to detail
Experience with Good Documentation Practices
Highly Desirable: Experience with Illumina (NovaSeq 6000) next-gen

Responsibilities

Perform routine quality control and laboratory maintenance procedures and proficiency testing in accordance with current laboratory SOPs
Aid the Quality Control Team in routine phase-in and performance qualification of reagents and instrumentation, respectively
Decontaminate laboratory equipment and work surfaces in accordance with current laboratory SOPs and routine cleaning to maintain clean, decluttered laboratory work areas
Perform routine, daily laboratory maintenance of NGS instrumentation
Participate in routine proficiency testing as required to ensure accuracy and reliability of laboratory testing results
Read and understand NGS SOPs required to perform routine clinical workflow procedures
Achieve mastery of NGS workflows post-competency by demonstrating adeptness in training of peers and in troubleshooting of workflow steps; and exhibiting a deep understanding of technical aspects of the workflow that allows for process optimizations recommendations
Perform routine diagnostic oncology testing using complex molecular-based procedures with a high degree of quality and in accordance with established SOPs
Perform next-generation sequencing, including DNA/RNA quantification and qualification; NGS library preparation and library clean-up; hybridization and capture cleanup and quantification; and sequencing on the Illumina Novaseq6000 and NovaX platforms
Enter clinical patient data obtained from routine testing into the Laboratory Information Management System (LIMS)
Maintain competency to perform all assigned molecular biology protocols and satisfy continuing education requirements of 12 CEUs in the field of oncology or molecular biology on a yearly basis in accordance with CAP, CLIA, NYSDOH regulations

Skills

NGS

Next-Generation Sequencing

Illumina Sequencing

Library Preparation

DNA/RNA Quantification

Hybridization Capture

Quality Control

Laboratory Maintenance

Molecular Diagnostics

SOP Compliance

Proficiency Testing

Oncology Testing

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters

2015Year Founded

$894.9MTotal Funding

IPOCompany Stage

AI & Machine Learning, Biotechnology, HealthcareIndustries

1,001-5,000Employees

Benefits

Relocation Assistance

Company Equity

Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.

Ambry Genetics acquisition could pose financial risks if synergies aren't realized.

Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.

Their platform aids in personalized treatment decisions for cancer patients.

Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.

Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.

Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI

Try Jobo Free